Generic Keppra (levetiracetam)

A generic version of the anti-convulsant medication Keppra, commonly used to treat patients that suffer from seizures, such as epileptics, was approved by the U.S. Food and Drug Administration (FDA) for marketing in 2009. However, it seems that patients who switch from Keppra to the generic, Levetiracetam, are experiencing increased re-occurance of seizures after having been seizure-free on the brand name Keppra.

In addition to treating patients with epilepsy or other seizure disorders, Keppra or Levetiracetam may be administered to patients who have had a traumatic brain injury (TBI) and had seizures from their brain injury.

All generic medications must undergo certain tests to compare them to brand-name medications. The FDA then looks at these tests to decide if the generics are equivalent to the brand-name medications.

However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.


Do you have a Generic Keppra claim?

The generic version of Keppra was only approved for marketing in 2009, so any injuries resulting from the switch from Keppra to generic would have occurred in 2009 or 2010. If you or a loved one has been injured as a result of generic Keppra (Levetiracetam), you may be entitled to compensation. For a free legal consultation, contact us today by filling out the brief questionnaire or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.